Insider Trading? Huge Bet Made Shortly Before STAT News Report Touting Gilead's Remdesivir ResultsChris Menahan
Apr. 20, 2020
Leftists Panic After Seeing 'White Men With LARGE GUNS' Defending Their Own Neighborhoods
Medical Examiner: George Floyd Was On Fentanyl, Died From A Heart Attack And Used Meth
Amazon Issues Statement Backing Protests As Their Drivers Are Being Attacked In The Streets
Fmr ESPN Reporter Celebrates Riots, Changes Tune After Nearby 'Gated Community' Is Attacked
WAR ZONE: SECOND Driver Filmed Ramming Cop in The Street in New York; Cop Beaten By Mob to Cheers [UPDATE: THIRD Attack]
STAT News writer Adam Fuerstein's market-moving article on Thursday touting leaked early trial results for Gilead's drug Remdesivir is raising suspicions and has one congressman calling for a Securities and Exchange Commission investigation.
Trader Tian Zeng on Thursday night highlighted a suspiciously timed large bet that Gilead's stock would surge within around 24 hours:
The mystery investor appears to have made a killing.
From CNN, "Congressman calls for SEC investigation into leak about possible coronavirus drug":
A congressman on Friday called for the Securities and Exchange Commission to investigate the leak of a video showing physicians at the University of Chicago speaking enthusiastically about an experimental drug to treat Covid-19.CNBC's Jim Cramer on Thursday touted Feuerstein as "the best there is and a great friend" and praised his article:
On Friday, CNBC also had Feuerstein on the air:
As I reported Friday, the media hyped this report massively with little skepticism -- despite being hyper-skeptical of hydroxychloroquine and relentlessly bashing Trump for touting it.
As Rep. Doggett said, this demands a thorough SEC investigation.
Follow InformationLiberation on Twitter, Facebook, Gab and Minds.